Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-24T19:21:27.550Z Has data issue: false hasContentIssue false

Reaching optimal iodine nutrition in pregnant and lactating women and young children: programmatic recommendations

Published online by Cambridge University Press:  01 December 2007

Juliawati Untoro
Affiliation:
Nutrition Section, Programme Division United Nations Children's Fund 3 UN PlazaNew York, NY, 10017, USA
Nune Mangasaryan
Affiliation:
Nutrition Section, Programme Division United Nations Children's Fund 3 UN PlazaNew York, NY, 10017, USA
Bruno de Benoist
Affiliation:
Nutrition for Health and Development (NHD) World Health OrganizationGeneva, Switzerland
Ian Darnton-Hill
Affiliation:
Nutrition Section, Programme Division United Nations Children's Fund 3 UN PlazaNew York, NY, 10017, USA
Rights & Permissions [Opens in a new window]

Abstract

Type
Editorial
Copyright
Copyright © The Authors 2007

The United Nations Children's Fund (UNICEF) and the World Health Organization (WHO) Joint Committee on Health Policy recommended Universal Salt Iodization (USI)Footnote 1 as a safe, cost-effective and primary sustainable strategy to ensure sufficient intake of iodine by all individuals1. It was also suggested to consider temporary iodine supplementation in areas of severe iodine deficiency where USI cannot be rapidly implemented. Although there has been considerable progress in the prevention and control of Iodine Deficiency Disorders (IDD) globally – over 70% households now use adequately iodized salt – it is estimated that there are still about 39 million infants born each year unprotected from the risk of cognitive damage from iodine deficiency.

Because of this and based on new evidence and lessons learned within the last decade, it appears that the most susceptible groups, pregnant and lactating women and children less than two years of age, might not be adequately covered by iodized salt where USI is not fully implementedReference Yan, Chen and Yang2Reference Dunn4. A fetus is totally dependent in early pregnancy on maternal thyroxine for normal brain development. Adequate maternal dietary intake of iodine during pregnancy is essential for maternal thyroxine production and later for thyroid function in the fetus. If iodine insufficiency leads to inadequate production of thyroid hormones and hypothyroidism during pregnancy, then this is likely to result in irreversible fetal brain damageReference Wada and King5, Reference Trimarchi, Lo Presti and Vermiglio6.

In order to address this issue, the WHO convened a technical consultation on the prevention and control of iodine deficiency in pregnant and lactating women and in children less than two years old. The consultation, held on 24–26 January 2005, Geneva, Switzerland, made recommendations to ensure optimum iodine nutrition among these groups and is reported in this issue7. As a follow up to the meeting, and in order to provide programmatic guidance to implement these recommendations within the country programme planning process, UNICEF and WHO held a joint meeting on 15–16 November 2005 at UNICEF Headquarters, New York, USA. This editorial presents the conclusions of the joint UNICEF/WHO meeting.

The primary strategy for sustainable elimination of iodine deficiency remains USI8. In some countries and areas, however, salt iodization programmes may not be implementable, thus resulting in insufficient access to iodine for some groups of the populationReference Yan, Chen and Yang2, Reference Angermayr and Clar9, Reference Untoro, Schultink, West, Gross and Hautvast10. In these cases, besides strengthening the USI programmes, additional complementary strategies such as iodine supplementation should be considered by the country to ensure optimal iodine nutrition for these susceptible groupsReference Yan, Chen and Yang2, Reference Angermayr and Clar9, Reference Allen11, Reference Cobra, Muhilal and Rusmil12. As the first step, countries need to assess and categorize the level of implementation of salt iodization programmes and, based on this analysis, should revisit the strategy for IDD control, as necessary.

Categorization of country according to level of implementation of salt iodization programmes

Countries or areas of countries can be categorized into four groups based on the proportion of household use of iodized salt at the national and sub-national levels. The joint consultation concluded that it is preferable for highly populated countries to use disaggregated data and categorize areas of the country according to sub-national (region, province, district) data:

Group I: Countries or areas of countries in which more than 90% of the households have access to iodized salt.

Group II: Countries or areas of countries in which 50–90% of the households have access to iodized salt.

Group III: Countries or areas of countries in which 20–50% of the households have access to iodized salt.

Group IV: Countries or areas of countries in which less than 20% of the households have access to iodized salt.

Guidelines for decision making on when and how to plan for additional iodine intake in pregnant and lactating women and children 7–24 months of age

Group I: The countries in this group should sustain the achievement of USI and periodically reassess the salt iodization programme and population iodine status.

Group II: The countries in this group should make efforts to accelerate salt iodization based on the existing operational guidelines8, 13. If no progress in scaling up is being made within two years, then the feasibility of increasing iodine intake in the form of a supplement or iodine fortified foods by the most susceptible groups– pregnant and lactating women and children 7–24 months of age–would need to be assessed, using the recommended strategy for the countries of group III.

Group III: The countries in this group will need to assess the feasibility of increasing iodine intake in the form of a supplement or iodine fortified complementary foods by the most susceptible groups, as described in the following programmatic steps.

  1. a. Assess population iodine nutrition status, household iodized salt coverage (preferably disaggregated) and salt iodization programmes in order to identify a national or sub-national problem. An initial rapid assessment will be needed for advocacy and for future monitoring, if no assessment has yet been made. The methodology of assessments is described in the ICCIDD/UNICEF/WHO guidelines on Assessment of Iodine Deficiency Disorders and Monitoring their Elimination13.

  2. b. Develop new plans to strengthen salt iodization that include increasing political commitment, advocacy, capacity building of the salt industry for production and quality assurance, adoption and enforcement of appropriate regulations/legislation, and an effective iodized-salt monitoring system at production (or importation), retail and community levels.

  3. c. The feasibility of increasing the iodine intake of susceptible groups in the form of supplements or iodine fortified food, will need to be explored as a temporary measure while strengthening the salt iodization programme. In areas of moderate IDD (median urinary iodine less than 50 μg/L or total goitre rate more than 20%), the objective should be to provide additional iodine in the form of a supplement to all pregnant and lactating women, and in the form of supplement or iodine fortified complementary food for children of 7–24 months of age.

  4. d. Assessing the feasibility of providing additional iodine should include: (i) costing of supplementation; (ii) existing channels for distribution to reach the target groups; (iii) likely duration of supplementation; and (iv) potential compliance.

Group IV: Each country in this group should assess the current situation of its salt iodization programme to identify national or sub-national problems and to update its strategies and action plans. The most vulnerable groups, pregnant and lactating women, should be supplemented with iodine and children 7–24 months of age should be given either a supplement or complementary food fortified with iodine until the salt iodization programme is scaled up.

Guidelines for decision making on when and how to plan for additional iodine intake in pregnant and lactating women and children 7–24 months of age in specific situations

Irrespective of where countries or areas of countries are categorized there are specific situations, such as in emergencies, among displaced people and geographically remote areas where additional iodine intake should be considered. If iodized salt is not accessible in these specific situations, increasing iodine intake is required in the form of iodine supplements for pregnant and lactating women and a supplement or complementary food fortified with iodine for children 7–24 months of age. In cases where it is difficult to reach pregnant women, supplementation to all women of reproductive age is advised.

Recommended dosages of iodine supplement

The consultation agreed on two main approaches for administering iodine supplementation on a daily basis or an annual basis using an iodized oil preparation, and endorsed the dose recommendations of the WHO as described in Table 17.

Table 1 Recommended dosages of daily and annual iodine supplementation

2 For children aged 0–6 months, iodine supplementation should be given through breast milk. This implies that the child is exclusively breastfed and that the lactating mother received iodine supplementation as indicated above.

3 These figures for iodine supplements are given in situations where complementary food fortified with iodine is not available, in which case iodine supplementation is required for children of 7–24 months of age.

Monitoring

Monitoring of IDD prevention and control programmes is crucial, whether they are based on fortification or supplementation, in order to ensure that additional iodine intake is both effective in reducing the deficiency while preventing excessive intake that may lead to adverse health consequences. The monitoring process should include the assessment of coverage and iodine nutrition status. The detailed methodology of monitoring is given in ICCIDD/UNICEF/WHO guidelines13.

Acknowledgements

The opinions in this Editorial are those of the authors and do not necessarily reflect the views of their organizations. None of the authors has competing interests.

The following individuals contributed to the statement in this editorial: Karen Codling, Nita Dalmiya, Francois Delange, Rainer Gross, Sunny Kim, Erin McLean, Eduardo Pretell, Werner Schultink, Catherine Shaw, Arnold Timmer, Maniza Zaman, and Michael Zimmerman.

Footnotes

1 Universal salt iodization (USI) means the iodization of salt for consumption by both humans and animals

References

1UNICEF/WHO. World Summit for Children - Mid-decade goal: Iodine Deficiency Disorders. UNICEF/WHO Joint Committee in Health Policy. Geneva: UNICEF/WHO, 1994.Google Scholar
2Yan, YQ, Chen, ZP, Yang, XM, et al. . Attention to the hiding iodine deficiency in pregnant and lactating women after universal salt iodization: A multi-community study in China. Journal Endocrinology Investigation 2005; 28: 547–53.CrossRefGoogle Scholar
3Delange, F. Administration of iodized oil during pregnancy: a summary of the published evidence. Bulletin World Health Organization 1996; 74: 101–8.Google ScholarPubMed
4Dunn, JT. Iodine supplementation and the prevention of cretinism. Annals of the New York Academy of Sciences 1993; 678: 158–68.CrossRefGoogle ScholarPubMed
5Wada, L, King, JC. Trace element nutrition during pregnancy. Clinical Obstetrics and Gynecology 1994; 37: 574–86.CrossRefGoogle ScholarPubMed
6Trimarchi, F, Lo Presti, VP, Vermiglio, F. Iodine deficiency and pregnancy. Annal Istiiuto Superiore Sanita 1998; 34: 315–9.Google ScholarPubMed
7WHO. Prevention and control of iodine deficiency in pregnant and lactating women, and in children less than two years old. Geneva: WHO, 2007 (In Press).Google Scholar
8UNICEF. The Roadmap towards achievement of sustainable elimination of iodine deficiency. Operational Guidance: 2005 and beyond. New York: UNICEF, 2005.Google Scholar
9Angermayr, L, Clar, C. Iodine supplementation for preventing iodine deficiency disorders in children. Cochrane Database of Systematic Reviews 2004: CD003819.CrossRefGoogle ScholarPubMed
10Untoro, J, Schultink, W, West, C, Gross, R, Hautvast, J. Efficacy of oral iodized peanut oil is greater than that of iodized poppyseed oil among Indonesian school children. American Journal of Clinical Nutrition 2006; 84: 1208–14.CrossRefGoogle Scholar
11Allen, LH. Multiple micronutrients in pregnancy and lactation: an overview. American Journal of Clinical Nutrition 2005; 81: 1206S–12S.CrossRefGoogle ScholarPubMed
12Cobra, C, Muhilal, , Rusmil, K, et al. . Infant survival is improved by oral iodine supplementation. Journal of Nutrition 1997; 127: 574–8.CrossRefGoogle ScholarPubMed
13ICCIDD/UNICEF/WHO. Assessment of Iodine Deficiency Disorders and Monitoring their Elimination. Geneva: World Health Organization, 2001.Google Scholar
Figure 0

Table 1 Recommended dosages of daily and annual iodine supplementation